论文信息 - Phase II Trial of MEK Inhibitor Binimetinib (MEK162) in RAS‐mutant Acute Myeloid Leukemia - 字舞流文

Phase II Trial of MEK Inhibitor Binimetinib (MEK162) in RAS‐mutant Acute Myeloid Leukemia

H. Kantarjian | G. Garcia-Manero | J. Cortes | T. Kadia | F. Ravandi | Koichi Takahashi | G. Borthakur | E. Jabbour | N. Daver | C. Dinardo | Y. Alvarado | M. Ohanian | A. Maiti | P. Bose | K. Naqvi | Ami Patel